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Abstract
Polymorphisms in BTBD9 have recently been associated with higher risk of restless legs syndrome (RLS), a neurological
disorder characterized by uncomfortable sensations in the legs at rest that are relieved by movement. The BTBD9 protein
contains a BTB/POZ domain and a BACK domain, but its function is unknown. To elucidate its function and potential role in
the pathophysiology of RLS, we generated a line of mutant Btbd9 mice derived from a commercial gene-trap embryonic
stem cell clone. Btbd9 is the mouse homolog of the human BTBD9. Proteins that contain a BTB/POZ domain have been
reported to be associated with synaptic transmission and plasticity. We found that Btbd9 is naturally expressed in the
hippocampus of our mutant mice, a region critical for learning and memory. As electrophysiological characteristics of CA3-
CA1 synapses of the hippocampus are well characterized, we performed electrophysiological recordings in this region. The
mutant mice showed normal input-output relationship, a significant impairment in pre-synaptic activity, and an enhanced
long-term potentiation. We further performed an analysis of fear memory and found the mutant mice had an enhanced
cued and contextual fear memory. To elucidate a possible molecular basis for these enhancements, we analyzed proteins
that have been associated with synaptic plasticity. We found an elevated level of dynamin 1, an enzyme associated with
endocytosis, in the mutant mice. These results suggest the first identified function of Btbd9 as being involved in regulating
synaptic plasticity and memory. Recent studies have suggested that enhanced synaptic plasticity, analogous to what we
have observed, in other regions of the brain could enhance sensory perception similar to what is seen in RLS patients.
Further analyses of the mutant mice will help shine light on the function of BTBD9 and its role in RLS.
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Introduction
Recently, two genome-wide association studies (GWAS) have
correlated polymorphisms in the BTBD9 gene with restless legs
syndrome (RLS) [1,2], a neurological disorder characterized by
unpleasant sensations in the legs at rest that are relieved by
movement [3]. The BTBD9 gene encodes a protein with two
structurally conserved domains. One domain is a bric-a ´-brac,
tramtrack, broad complex (BTB)/pox virus and zinc finger (POZ)
domain near the N-terminus, which has been associated in other
proteins with transcriptional regulation, cytoskeleton dynamics,
ion conductance, and protein ubiquitination [4]. The other
domain is a BTB and C-terminal kelch (BACK), which has been
associated in other proteins with maintaining proper substrate
orientation, primarily for E3 ubiquitin-ligase complexes [5].
Previous studies have shown that the mRNA of the Btbd9 gene,
the mouse homolog of the human BTBD9 gene, was down-
regulated in a model of Lesch-Nyhan syndrome [6], a neurological
disorder sometimes referred to as juvenile gout; and in an
embryonic stem cell line that lacks the amyloid precursor proteins
App and Aplp2, which are involved in synaptic formation and
repair [7,8]. Contrastingly, in baboons that consumed moderate
and high levels of docosahexaenoic acid, which is an important
fatty acid in the central nervous system and during development,
BTBD9 mRNA was up-regulated [9–11]. Additionally, Btbd9 gene
expression has been correlated with the level of iron in the
midbrain of an inbred strain of mice [12]. Finally, previous studies
using in situ hybridization showed that Btbd9 mRNA was expressed
in several brain regions, including the thalamus, hypothalamus,
cortex, striatum and hippocampus, and also expressed in all levels
of the spinal cord [13]. All of these studies, however, have been
limited in scope in examining the function of the BTBD9 protein in
vivo and its potential role in the pathophysiology of RLS.
Proteins containing similar domains to BTBD9 have been
implicated in a variety of aspects of synaptic plasticity and
transmission. For instance, abrupt, a BTB-zinc finger protein in
Drosophila melanogaster, has been shown to be involved in proper
motor neuron targeting and dendritic branching [14,15]. Addi-
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melanogaster, led to an increase in dendritic branching, while a loss
of kelch inhibited dendritic branching [16]. KEL-8, another BTB-
Kelch protein in the nematode Caenorhabditis elegans, was shown to
be a critical component of ubiquitin-mediated turnover of the
glutamate receptor GLR-1 [17]. Similarly, actinfilin, a brain-
specific BTB-Kelch protein in rats, was shown to regulate the
ubiquitin-mediated turnover of the glutamate receptor GLR-6
[18,19].
We attempted to elucidate the function of Btbd9 and its
potential role in the pathophysiology of RLS by creating a
knockout of the Btbd9 gene in mice. We found that the Btbd9
protein was naturally expressed in the hippocampus, a brain
region critical for learning and memory. Additionally, a study of
non-medicated RLS patients showed minor increases in gray
matter density of the ventral hippocampus [20], but the
consequential effects were not investigated. As the CA3-CA1
Schaffer collateral synapses of the hippocampus are well
characterized using electrophysiological techniques and are
glutamate-mediated, we analyzed the homozygous Btbd9 mutant
mice in this region. We found that the Btbd9 mutant mice
exhibited enhanced long-term potentiation (LTP) and paired-pulse
ratios (PPRs). Furthermore, we have found that the Btbd9 mutant
mice had an enhanced cued and contextual fear memory. Lastly,
we found that the Btbd9 mutant mice had an increase in levels of
dynamin 1, an enzyme associated with endocytosis. Therefore, our
data, taken together, suggest that the first known function of the
Btbd9 protein is that it is involved in regulating hippocampal
synaptic plasticity and learning and memory.
Materials and Methods
All experiments were carried out in compliance with the
USPHS Guide for Care and Use of Laboratory Animals and
approved by the Institutional Animal Care and Use Committee at
the University of Alabama at Birmingham (Protocol #
090908921).
Generation of the Btbd9 knockout mice
We obtained a commercial embryonic stem (ES) cell clone that
harbored a b-geo gene trap vector in the sixth intron of the Btbd9
gene (RRE078, BayGenomics). The gene trap was approximately
8.5 kilobase pairs (kb) long and included a single exon of the
Engrailed-2 (En2) gene fused to coding regions of the bacterial lacZ
and neomycin phosphotransferase II genes. The En2 exon contained a
59-splice site, while at the end of the b-geo gene trap there was a
polyadenylation (pA) signal sequence. These two sequences, the
splice acceptor site and the pA signal sequence, created a new
exon within the sixth intron of the Btbd9 gene, which should
terminate transcription at the end of the gene trap, and produce a
fusion protein that contains the N-terminal portion of the Btbd9
protein and a b-galactosidase/neomycin fusion protein. The ES
cells were expanded and its fusion mRNA verified by RT-PCR
(data not shown). After insertion of the expanded ES cells into
blastocysts, they were implanted into pseudopregnant females, and
chimeras were generated. Chimeras that successfully transmitted
to germline the mutated Btbd9 gene and passed it to their offspring
were detected by PCR using primers designed to target and
amplify a sequence within the gene trap vector (v1531 – 59-
GGTCCCAGGTCCCGAAAACCAAAGAAGA-39 and v1842R
–5 9-ACAGTATCGGCCTCAGGAAGATCGC-39). Heterozy-
gous mutant mice were interbred to generate homozygous mutant
mice, which were identified initially using a microsatellite marker
approximately 4 megabase pairs from the Btbd9 gene, which can
identify differences between mouse inbred strains (D17M100a –
59-GTTAAGAATGATTTTCACACTACAAGA-39 and
D17M100b – 59-AGCACATGTACTTACTCATATACGTGC-
39). The size of PCR products from 129/SvJ strain is 129 bp,
which represents that of the mutant allele from the ES cell, while
those from C57BL6J is 119 bp, which represents that of the wild-
type allele from the backcross. To determine the location of the
gene trap vector within the sixth intron of the Btbd9 gene, we used
long and accurate (LA)-PCR. With LA-PCR we were able to
successfully amplify sequences up to approximately 20 kb, which
was important as the length of the sixth intron of the Btbd9 gene is
approximately 179.2 kb long. We synthesized primer sets at
approximately 10 kb intervals within the sixth intron (Table S1),
and then serially amplified approximately 10 kb fragments (Figure
S1A) and screened for failure of LA-PCR reactions using genomic
template DNA isolated from the homozygous mutant mice. We
were able to narrow down the approximate location of the gene
trap in the sixth intron to a 13.2 kb region between approximately
89.3 kb and 102.5 kb from the start of the sixth intron. Next, we
synthesized primer sets at approximately 500 bp intervals in this
region and conducted PCR (Table S1). This narrowed the possible
insertion site further to 102,000 to 102,501 bp from the start of the
sixth intron (Figure S1B). Lastly, we generated a primer set located
at 102,200 bp from the start of the sixth intron and conducted
PCR (Table S1). This narrowed the insertion site to between
102,200 and 102,501 bp from the start of the sixth intron (Figure
S1B). Mice were backcrossed to the C57BL/6 background.
Mating was conducted by interbreeding heterozygous Btbd9
mutant mice to generate experimental mice. Mice were genotyped
by PCR using a primer set designed to detect the wild-type strain
(102000A – 59-ctgagatgattaacaagagctgagggct-39 and 6ERA – 59-
tcagccacgtcttctaaatgtaatggtt-39, Figure 1B, Figure S1C) and a
primer set designed to detect the mutant strain (v1531 and
v1842R, Figure 1B, Figure S1C, Table S2) together with a set of
primers to serve as internal controls (102000B – 59- AGATGAT-
TAACAAGAGCTGAGGGCT -39 and 102200R – 59-ACAC-
TAAGCTTTCCCACGGGTGCACAT-39). In all experiments,
adult homozygous Btbd9 mutant mice and littermate wild-type
(WT) control C57BL/6 mice were used.
RT-PCR
mRNA was obtained from 2 WT and 2 homozygous Btbd9
mutant mice brains using a Qiagen RNeasy Protect Kit. RT-PCR
was performed using protocols from Qiagen OneStep RT-PCR kit
with the forward primer located in the exon before the intron
containing the gene-trap (Exon6 – 59-TTGAAGTGTCCATG-
GACGAACTTGATTGGA-39) and the reverse primer located in
the exon after this intron (Exon7R – 59-GAAAATCTTGTT-
CACTGTGTTGTGAGTCC-39).
Electrophysiology: field recordings
Recordings were conducted from 6 WT and 6 homozygous
Btbd9 mutant mice. Preparation of hippocampal slice and
electrophysiological analysis were performed as described previ-
ously [21–23]. In brief, hippocampi of adult mutant or wild type
mice were rapidly removed and briefly chilled in ice-cold cutting
saline (110 mM sucrose, 60 mM NaCl, 3 mM KCl, 1.25 mM
NaH2PO4, 28 mM NaHCO3, 5 mM D-glucose, 500 mM CaCl2,
7 mM MgCl2, and 600 mM ascorbate). Transverse slices 400-mm
thick were prepared with a Vibratome and maintained at least
45 min in a holding chamber containing 50% artificial cerebral
spinal fluid (aCSF) (125 mM NaCl, 2.5 mM KCl, 1.25 mM
NaH2PO4, 25 mM NaHCO3, 25 mM D-glucose, 2 mM CaCl2,
and 1 mM MgCl2) and 50% cutting saline. The slices were then
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100% aCSF. Slices were allowed to equilibrate for 60–90 min in a
Fine Science Tools interface chamber at 30uC. All solutions were
continuously bubbled with 95% O2/5% CO2. For extracellular
field recordings, glass recording electrodes were filled with aCSF
and placed in the stratum radiatum of the CA1 hippocampal
region. Test stimuli were delivered to the Schaffer collateral/
commissural pathway with bipolar Teflon coated platinum
stimulating electrode positioned in the stratum radiatum of the
CA3 hippocampal region. Responses were recorded using a
computer with AxoClamp pClamp 8 data acquisition software.
Excitatory post-synaptic potential (EPSP) slope measurements
were taken after the fiber volley to eliminate contamination by
population spikes. Following at least 20 min of stable baseline
recording, long-term potentiation (LTP) was induced with two,
100 Hz tetani (1 second), with an interval of 20 seconds between
tetani. Synaptic efficacy was monitored by recording fEPSPs every
20 seconds beginning 0.5 hr prior to induction of LTP and ending
3 hr after induction of LTP (traces were averaged for every 2 min
interval). Paired pulse ratios (PPRs) were measured at various
inter-stimulus intervals (10, 20, 50, 100, 150, 200, 250, and
300 ms). All experimental stimuli were set to an intensity that
evoked 50% of the maximum field EPSP (fEPSP) slope. To
measure input-output relationships, test stimuli were delivered and
responses recorded at 0.05 Hz with every six consecutive
responses over a 2 min period pooled and averaged. fEPSPs were
recorded in response to increasing intensities of stimulation (from
2.5 mA to 45.0 mA).
Electrophysiology: whole-cell recordings
Recordings were conducted from 3 juvenile WT mice and 2
homozygous Btbd9 mutant littermates. Animals were anesthetized
by the inhalation of isoflurane, decapitated and the brain was
rapidly removed. 400 mm-thick coronal brain slices were cut with
a Vibratome (Technical Products International, St. Louis, MO).
Slices were incubated on cell culture inserts (8 mm pore diameter,
Becton Dickinson, Franklin Lakes, NJ) covered by a thin layer of
artificial cerebrospinal fluid (ACSF) containing (in mM) 124 NaCl,
26 NaHCO2, 1.25 NaH2PO4, 2.5 KCl, 1 CaCl2, 6 MgCl2,1 0D -
glucose and surrounded by a humidified 95% O2 and 5% CO2
atmosphere at room temperature (22uC). After at least 1 hr
incubation, the slice was transferred to a submerged recording
chamber with continuous flow (2 ml/min) of ACSF as described
above except for 2.4 mM CaCl2 and 1.3 mM MgCl2 and gassed
with 95% O2-5% CO2 giving pH 7.4. All experiments were
carried out at 30uC. Whole-cell recordings were made from
pyramidal cells in the hippocampal CA1 region using infrared-
differential interference contrast microscopy and an Axopatch 1D
amplifier (Axon Instruments, Foster City, CA). Patch electrodes
had a resistance of 3–5 MV when filled with intracellular solution
containing (in mM): 125 K-gluconate, 8 NaCl, 10 HEPES, 4
MgATP, 0.3 Na3GTP, 0.2 EGTA, and 0.1% biocytin (pH 7.3
with KOH, osmolarity 290–300 mOsM). mEPSCs were recorded
at 268 mV and with the both solution containing 1 mM TTX(a
sodium channel blocker, 50 mM AP5(an NMDA receptor blocker)
and 50 mM picrotoxin (a blocker of GABA receptor). Series
resistance was 9–15 MV and cells were rejected if it changed
.10% throughout the recording session. All drugs were purchased
from Sigma-Aldrich. Data were acquired using pClamp 10
software. The recordings were started 5–10 min after accessing
the cell to allow for stabilization of spontaneous synaptic activity.
Analysis of mEPSCs was based on 5 min continuous recordings
from each cell. Events were detected using the Mini Analysis
Program (Synaptosoft) with parameters optimized for each cell
and then visually confirmed prior to analysis. The peak amplitude,
10–90% rise time and the decay time constant were measured
based on the average of all events aligned by rise phase.
Figure 1. Generation and genotyping of Btbd9 mutant mice. (A) The normal wild-type (WT) allele of the Btbd9 gene contains 12 exons. A
commercially available mutant allele of the Btbd9 gene has a b-geo gene trap inserted into the sixth intron. Filled vertical rectangles represent coding
exons; open vertical rectangles represent non-coding exons. (B) To genotype the mice a two-step process was taken. First, primers were used to
detect specifically the b-geo gene trap vector, which produced a fragment of approximately 311 bp in length with an internal control fragment of
approximately 200 bp in length. Second, primers were used to detect specifically a WT allele, which would produce a fragment of approximately
500 bp in length and an internal control b-geo fragment of 311 bp in length.
doi:10.1371/journal.pone.0035518.g001
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Memory formation and recall was assessed by contextual and
cued fear conditioning test as previously described [22,24]. In
brief, 20 WT mice and 15 homozygous Btbd9 mutant mice were
trained during the morning of the first day in contextual chambers
with wire shock grid floors. Mice were first allowed to explore the
context for four min before presentation of the first 30 seconds
tone at 90 dB, which co-terminated with a 1 second, 0.5 mA
electrical foot shock. Two tone-shock pairings were presented in
total with a shock interval of 120 seconds. Mice remained in the
chamber for an additional 60 seconds before being returned to
their home cages. The chamber was cleaned with 70% ethanol
between animals. The next morning mice were monitored in the
context chambers for their freezing behavior for 5 min, without
the presentation of tone or shock. In the afternoon, the attributes
of the environment were significantly altered. Mice were then
allowed to explore this novel environment for 3 min before
presentation of the tone, without shock, for 3 min. The chamber
was cleaned with 75% isopropanol between animals. Response to
the electric shocks during the training phase was conducted by an
investigator blind to the genotypes of the mice, on two rating
scales. The first scale measured the gross response to the electric
shock, and a score of 1 to 3 was given, where 1 represented no
response, 2 represented flinching or modest interrupting in
ongoing behavior but did not generate any gross movement, and
3 represented running or jumping or major interruption in
ongoing behavior that generated gross movements. As all mice in
the fear conditioning experiment responded with level 3 responses,
the investigator then rated the response on a scale of 1 to 5, where
1 is a minimal but gross movement in response to the shock and 5
is a very large gross movement in response to the shock. The time
each mouse spent without any movement during the test was
counted as freezing behavior. Freezing behavior was monitored
and recorded by video and evaluated by software (Video Freeze,
Med Associates). The freezing time (seconds) was divided by
session time (for context, 5 min; for cued, 3 min) and expressed as
percent freezing. Finally, we measured electrical shock pain
threshold as previously described [25]. In brief, we systematically
applied increased shock intensities from 0.1 mA to 1.0 mA to 7
WT mice and 6 homozygous Btbd9 mutant mice. Intensities at
which the mouse flinched, jumped, or vocalized were recorded
and analyzed.
Western blot
Two types of fractions were used depending on the experiment.
The first was a whole hippocampus fraction and the second was a
synaptosomal fraction, both from 3 WT mice and 3 homozygous
Btbd9 mutant mice. In both cases, the hippocampi were dissected
and quickly frozen in liquid nitrogen. Whole hippocampus fraction
preparation was performed as previously described [23,26,27]. In
brief, the hippocampi were then homogenized in 400 mL of ice-
cold lysis buffer [50 mM Tris?Cl (pH 7.4), 175 mM NaCl, 5 mM
EDTA, Complete Mini Protease Inhibitor Cocktail (Roche)] and
sonicated for 10 seconds. One-ninth volume of 10% Triton X-100
in lysis buffer was added to the homogenates. The homogenates
were incubated for 30 min on ice, and then centrifuged at
10,0006 g for 15 min at 4uC. The supernatants were then
collected and the protein concentration was measured by Bradford
assay with bovine serum albumin as standards. The homogenates
were mixed with SDS-PAGE loading buffer and boiled for 5 min,
incubated on ice for 1 minute, and then centrifuged for 5 min to
obtain the supernatant for loading at 40 mg each lane. Synapto-
somal fractions were prepared as previously described [26,28]. In
brief, the hippocampi were defrosted in 5 mL of ice-cold TEVP
buffer [10 mM Tris-Cl (pH 7.4), 5 mM NaF, 1 mM Na3VO4,
1 mM EDTA, 1 mM EGTA] containing 320 mM sucrose for
5 min and homogenized. The homogenates were centrifuged for
10 min at 8006 ga t4 uC and the supernatants were collected.
Supernatants were then centrifuged for 15 min at 9,2006 g and
the pellets were obtained. After briefly rinsing with 1 mL TEVP
buffer containing 35.6 mM sucrose, pellets were resuspended in
2 mL TEVP buffer containing 35.6 mM sucrose and put on ice
for 30 min. The samples were vortexed and centrifuged for
20 min at 25,0006ga t4 uC. Pellets were briefly rinsed with 1 mL
of TEVP buffer and resuspended in 1 mL TEVP buffer. These
synaptosomal fractions were sonicated for 10 seconds and the
protein concentration was measured by Bradford assay with
bovine serum albumin as standards. Synaptosomal fractions were
diluted with water containing Complete Mini Protease Inhibitor
Cocktail (Roche) and mixed with equal volume of 26SDS-PAGE
loading buffer to the final protein concentration of 0.5 mg/mL. The
solution was then boiled for 5 min, incubated on ice for 1 min,
and centrifuged for 5 min to obtain the supernatant for loading at
10 mg each lane. In both fractions, the separated proteins were
transferred to the nitrocellulose membrane. The membrane was
blocked with 5% milk in wash buffer and treated with the primary
antibody of the protein of interest. The secondary antibodies and
detecting reagents were the same as previously described. The
experiments were performed in triplicate. For whole hippocampus
fraction the antibody used was against b-galactosidase (55976, MP
Biomedicals) and for synaptosomal fraction the antibodies used
were against syntaxin-1 (PA1-1042, Affinity BioReagents), SNAP-
25 (SC-7538, Santa Cruz), synaptotagmin-1 (AB9202, Millipore),
synaptobrevin-2 (018-15791, Wako), synaptophysin (PA1-1043,
Affinity BioReagents), and dynamin 1 (SC-6402, Santa Cruz).
Statistics
Long-term potentiation (LTP) and paired-pulse ratios (PPRs)
were analyzed using a Student’s t-test. Input-output relationships
were analyzed at individual intensities using a Student’s t-test and
the overall distribution was analyzed using a Kolmogorov-
Smirnov test. Miniature excitatory post-synaptic current (mEPSC)
amplitude and frequency was analyzed using a Kolmogorov-
Smirnov test, while rise and decay times were analyzed using a
Student’s t-test. Graphical data shows approximately 97–98% of
mEPSC data for simplicity. Western blot analyses were conducted
using a Student’s t-test. Fear conditioning behavior response to the
shock during training was analyzed using Wilcoxon rank-sum test,
using SAS 9.1 software. Shock threshold was analyzed for each of
three behaviors using a Student’s t-test. Fear conditioning freezing
analysis was conducted by mixed-model ANOVA taking into
consideration age, sex, and bodyweight interactions, using SAS 9.1
software. Significance was assigned at p#0.05.
Results
To examine the function of the Btbd9 protein in vivo,w e
generated a knockout of the Btbd9 gene in mice using a b-geo gene
trap vector inserted into the sixth intron. Interbreeding heterozy-
gous Btbd9 mutant mice resulted in a non-Mendelian ratio at
weaning, with a decrease in both heterozygous and homozygous
Btbd9 mutant mice (p,0.05, Table 1). There were no obvious
abnormalities in these mice, including weight at time of
experiment, ability to right themselves, and gait. To determine
how effective the gene trap was in terminating transcription, we
used reverse transcriptase (RT)-PCR with the forward primer
located in the exon before the gene trap and the reverse primer
located in the exon after the gene trap. The wild-type (WT) mice,
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strong RT-PCR fragment (Figure 2A). This suggests that the gene
trap efficiently knocked out the Btbd9 gene. Furthermore, as there
are currently no high-quality commercially available antibodies for
Btbd9 in mice, we took advantage of the mutant mice having the
bacterial lacZ gene inserted into the Btbd9 gene as part of the gene
trap, which produces a b-galactosidase-neomycin fusion protein.
Using an antibody against b-galactosidase, we were able to identify
that Btbd9 is normally expressed in the hippocampus of mice
(Figure 2B). The Btbd9 mutant mice produced two bands
compared to one band by the positive control, which could be
attributed to alternate splicing of the Btbd9 gene [29]. The
expression of the Btbd9 gene in the hippocampus of mice is similar
to the result produced by the Allen Mouse Brain Atlas using in situ
hybridization of Btbd9 mRNA [13].
As the hippocampus has been implicated in learning and
memory and extensively studied using electrophysiological tech-
niques, we performed field recordings in hippocampal slices in the
CA1 region to determine whether the Btbd9 mutant mice have any
electrophysiological alterations. To test for post-synaptic deficits in
the Btbd9 mutant mice, we obtained input-output curves, which
measure the post-synaptic potential slope versus varying stimulus
intensities. Btbd9 mutant mice showed no change in their input-
output relationship at individual stimulus intensity values and no
change in the distribution of the curve compared to WT mice
(p.0.05; Figure 3A). Next, to examine short-term plasticity in the
Btbd9 mutant mice we looked at paired-pulse ratios (PPRs), which
test the ability of two stimuli separated by varying time intervals to
elicit an increased post-synaptic response. PPRs at three different
inter-stimulus intervals were significantly enhanced in the Btbd9
mutant mice compared to WT mice (p,0.05; Figure 3B). This
suggests that the Btbd9 mutant mice had a decrease in the
probability of synaptic vesicle release from the pre-synaptic
terminal. Next, to examine long-term plasticity in the Btbd9
mutant mice we examined long-term potentiation (LTP). Btbd9
mutant mice compared to WT mice had a significant enhance-
ment in late CA1 LTP (p,0.05; Figure 3C). This suggests that the
Btbd9 mutant mice had an enhancement in long-term plasticity.
Lastly, to further explore these alterations, we examined miniature
excitatory post-synaptic currents (mEPSC) for alterations in
amplitude, frequency, and rise and decay times. We found that
the Btbd9 mutant mice have decreased frequency and amplitude of
mEPSC events compared to WT mice (p,0.01, Figure 4B), but no
alteration in the rise and decay times (p.0.05, Figure 4C).
Decreased frequency suggests that the number of vesicles released
at rest is decreased, while decreased amplitude suggests that the
amount of glutamate per synaptic vesicle, the post-synaptic
response to a single synaptic vesicle, or both, could be decreased.
Additionally, the data suggest that there is no change in the
kinetics of the post-synaptic receptors, such as opening and closing
of their respective channels.
As alterations in hippocampal long-term potentiation have been
associated with alterations in hippocampal learning and memory,
we performed a classical fear conditioning to test both cued fear
memory, freezing behavior caused by an auditory stimulus, and
contextual fear memory, freezing behavior caused by recall of the
environment or context (Figure 5A). The Btbd9 mutant mice
exhibited no behavioral response difference to the shock during
the training period (p.0.05, Figure S2B). Moreover, the Btbd9
mutant mice had no difference in the electrical shock required to
elicit flinching, jumping, and vocalization behaviors (p.0.05,
Figure S2A). This suggests that the Btbd9 mutant mice do not have
altered perception to the electrical shock. However, we found that
the Btbd9 mutant mice had an enhancement of both cued (p,0.05,
Figure 5B) and contextual (p,0.05, Figure 5B) fear memory. This
suggests that the Btbd9 mutant mice have an enhancement in
learning and memory that correlates with the enhanced LTP.
To explore the molecular basis for the pre-synaptic alteration in
the Btbd9 mutant mice, we performed Western blot analyses to
determine the level of several proteins involved in the Soluble NSF
Attachment Protein Receptor (SNARE) complex, which are
involved in synaptic vesicle docking, fusion, and endocytosis. We
first determined the levels of the target-SNAREs syntaxin-1 and
SNAP-25 and the vesicular-SNAREs synaptotagmin-1 and
synaptobrevin-2. We also examined the levels of endocytosis
proteins synaptophysin and dynamin 1. We found no statistical
difference in the protein levels of synataxin-1, SNAP-25,
synaptobrevin-2, synaptotagmin-1, or synaptophysin suggesting
there is no functional alteration in vesicular docking or fusion
events (p.0.05, Figure S3A-E). However, there was a significant
increase in the level of dynamin 1 in the Btbd9 mutant mice
(p,0.05, Figure 6).
Discussion
To understand the function of the BTBD9 protein in vivo and its
potential role in the pathophysiology of restless legs syndrome
(RLS), we generated a knockout of the Btbd9 gene, the mouse
Figure 2. Confirmation of loss of WT mRNA and fusion protein
expression in mutant hippocampus. (A) The WT mice, in contrast
to the homozygous Btbd9 mutant mice, produced a strong RT-PCR
fragment of the Btbd9 gene. (B) The Btbd9 protein is expressed in the
hippocampus of adult mice. Antibody against b-galactosidase detected
b-geo fusion proteins from both the Btbd9 mutant and a positive
control mouse that had a gene trap insertion in a different gene, while
no band was observed in the WT control.
doi:10.1371/journal.pone.0035518.g002
Table 1. Non-Mendelian ratios of pups from heterozygous
Btbd9 mutant mice interbreeding.
Genotype Expected Observed
Chi-square
value p-value
WT 20.5 35 - -
Het 41 34 9.391 0.0022*
KO 20.5 13 10.083 0.0015*
Total 82 82 14.195 0.0008**
WT, Wild-type mice; Het heterozygous Btbd9 mutant mice; KO, homozygous
Btbd9 mutant mice;
*p,0.05,
**p,0.001.
doi:10.1371/journal.pone.0035518.t001
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expressed in the hippocampus. We further found that the
homozygous Btbd9 mutant mice exhibited alterations in hippo-
campal paired-pulse ratios (PPRs), a measure of short-term
plasticity, and hippocampal long-term potentiation (LTP), which
is a measure of long-term plasticity. Additionally, we found that
the homozygous Btbd9 mutant mice exhibited decreased frequency
and amplitude of miniature EPSC (mEPSC) events. Furthermore,
the homozygous Btbd9 mutant mice had enhanced cued and
contextual fear memory. Lastly, the homozygous Btbd9 mutant
mice had an increase in the levels of dynamin 1, an enzyme
associated with endocytosis.
We first examined the electrophysiological characteristics of the
Schaffer collateral CA3-CA1 pyramidal neurons, which use
glutamate as its neurotransmitter, in the Btbd9 mutant mice. We
found that the Btbd9 mutant mice have an enhanced late long-
term potentiation. LTP is a measure of long-term synaptic
transmission and strength between pre- and post-synaptic neurons
on the order of hours to days and is believed to underlie the
learning and memory process [30,31]. LTP can be broken into
two temporal categories – early and late. It is hypothesized that
early LTP is modulated by properties of the pre- and post-synaptic
neurons, such as resting membrane potentials, voltage-gated
calcium channels, and neurotransmitter receptors. Late LTP,
unlike early LTP, is believed to be protein synthesis-dependent
due to its extended time period [32,33]. This is done through
alterations in gene expression, possibly through transcription
factors and kinases such as cAMP response element binding
protein (CREB) and the mitogen-activated protein (MAP) kinase
family [34]. To examine the effects of this alteration in late LTP in
the Btbd9 mutant mice, we measured cued and contextual fear
memory. While fear memory is generally thought to be controlled
by the amygdala, there is an extensive body of information
supporting the role of the hippocampus in fear memory, in
particular contextual fear memory [35–39]. We have found that
the Btbd9 mutant mice have an enhanced cued and contextual fear
memory. In restless legs syndrome, patients often have abnormal
sensations in their legs during rest and at night. Furthermore, a
recent report showed that there is a decrease in pain threshold and
temporal summation of heat pain in RLS patients [40]. The
authors suggest that this could be attributed to an alteration in the
central nervous system pain processing centers, which could lead
to persistent pain conditions [40]. Recent studies have also
suggested that an enhanced synaptic plasticity in nociceptive
pathways can cause heightened pain awareness [41–44]. In
particular, nociceptive nerves can undergo long-term potentiation,
which has been suggested as a possible mechanism underlying
hyperalgesia [45]. Therefore, we speculate that enhanced synaptic
plasticity or potentiation, as seen here in the hippocampus, could
be present elsewhere in the Btbd9 mutant mice, such as sensory or
nociceptive centers in the central nervous system, and underlie
potential sensory and nociceptive deficits in RLS patients. Further
studies will need to be conducted to examine this.
Furthermore, in the electrophysiological recordings we found
that the Btbd9 mutant mice had enhanced paired-pulse ratios, a
measure of neural facilitation, which is the ability of a second
Figure 3. Hippocampal CA1 electrophysiological field record-
ings. (A) Btbd9 mutant mice showed no differences in input-output
relationships. Small inset graph is a representative trace with varying
stimulus intensities. (B) Btbd9 mutant mice showed enhanced paired-
pulse ratios at three inter-stimuli values. Panel above graph are
representative traces at the three inter-stimuli values that were
significantly different between Btbd9 mutant and WT mice. (C) Btbd9
mutant mice showed enhanced late long-term potentiation. Small inset
graphs are representative traces, with red signifying before LTP
induction and black signifying after LTP induction. Circles represent
means 6 SEM. * p,0.05.
doi:10.1371/journal.pone.0035518.g003
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35518impulse to evoke the further release of synaptic vesicles from the
pre-synaptic terminal. PPRs are on the order of milliseconds and
seconds and therefore a measure of short-term plasticity. PPRs
have been associated with an inverse probability of synaptic vesicle
release, where increases in PPRs are indicative of a decreased
probability of synaptic vesicle release and vice versa. We therefore
Figure 4. Hippocampal CA1 electrophysiological whole-cell recordings. (A) Representative traces of mEPSC recording from WT and Btbd9
mutant mice. (B) Btbd9 mutant mice showed a decrease in both frequency and amplitude of mEPSC events compared to WT mice (p,0.01 each). (C)
Btbd9 mutant mice showed no difference from WT in rise and decay times of mEPSC events. Bars represent means 6 SEM.
doi:10.1371/journal.pone.0035518.g004
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plasticity. We found that the Btbd9 mutant mice have an elevated
level of dynamin 1. Dynamin is a GTPase associated with the
cleavage of vesicles from the membrane during endocytosis [46]. A
previous study showed that dynamin 1 knockout mice have a
decrease in synaptic vesicle recycling, possibly due to an inability
of vesicles to free themselves from the membrane [47].
Additionally, in a recent study decreases in dynamin levels were
associated with memory impairment in a rat model of Alzheimer’s
disease [48]. Furthermore, treatment of these rats with meman-
tine, a classic NMDA antagonist used to treat Alzheimer’s disease,
resulted in decreased dynamin 1 degradation and increased
memory ability [48]. This study closely correlates with our results
by showing a relation between dynamin and learning and
memory.
A recent proteomic study examining the ubiquitination system
identified 774 candidate interacting proteins associated with
deubiquitinating enzymes [49]. Of these, BTBD9 was associated
with ubiquitin specific peptidase 21 (USP21) and COP9
constitutive photomorphogenic homolog subunit 6 (CSN6) [49].
In addition, the BTBD9 protein is known to have a BACK
domain, which is important in substrate orientation for ubiquitin
complexes [5]. These data suggests that BTBD9 might be involved
in the ubiquitination system. We speculate that BTBD9 through its
interactions with USP21 and CSN6 plays a role in the turnover of
dynamin 1. Therefore, in the Btbd9 mutant mice, the loss of the
Btbd9 protein could lead to a decreased degradation of dynamin 1,
which results in an elevated level of dynamin 1, as observed.
Dynamin 1 thereby can alter the characteristics of synaptic
function, such as long-term potentiation, which can influence
memory performance.
The Btbd9 mutant mice have enhanced PPRs, which is
suggestive of a pre-synaptic impairment, but have no alteration
in input-output relationships, in which a pre-synaptic neuron is
stimulated at varying intensities and the response of a post-
synaptic neuron is recorded. We speculate that either in the Btbd9
mutant mice there is a post-synaptic enhancement, which
compensates for a pre-synaptic impairment; or, the input-output
relationship measurement is not sensitive enough to measure the
effects of the pre-synaptic deficit on the post-synaptic neuron. To
potentially differentiate between these two, we measured mEPSC
events. In this experiment action potentials from the pre-synaptic
neurons are blocked, and only spontaneous, action potential
independent vesicular release is allowed. We observed that the
Btbd9 mutant mice have decreased frequency and amplitude of
mEPSC events. Decreased frequency suggest that there is a
decrease in synaptic vesicle release at rest, which correlates with
the PPRs, while decreased amplitude suggest a decrease in quantal
size of vesicular glutamate, a decrease in unit post-synaptic
response, or both. It is worth noting that it has been suggested that
evoked responses, such as input-output relationships, and
spontaneous responses, such as mEPSC, may not be directly
compared due to different synaptic mechanisms underlying them
[50]. Further examination of the pre-synaptic and post-synaptic
terminals will be conducted in future studies.
Furthermore, in the Btbd9 mutant mice there is an enhancement
of late long-term potentiation, while there is no change in early
long-term potentiation. We speculate that there is no change in
early long-term potentiation either because the Btbd9 mutant mice
have an alteration in the post-synaptic neuron that can
compensate for pre-synaptic deficits, or Btbd9 as a protein involved
in the ubiquitination system is altering the longevity of proteins
involved in synaptic plasticity. Additionally, late long-term
potentiation requires changes in protein synthesis, which we
speculate carries different properties than that of the PPRs.
Figure 5. Freezing behavior in fear conditioning experiment.
(A) Btbd9 mutant mice and WT mice were conditioned to two 30-
second tones followed by an electric shock, with a shock interval of
120 seconds. Solid black rectangle represents the period of tone. The
vertical line at represents the period of the shock. (B) Btbd9 mutant
mice had increased percentage of freezing behavior in both contextual
and cued fear conditioning, suggesting that the Btbd9 mutant mice had
enhanced fear memory. Vertical bars represent means 6 SEM. * p,0.05.
doi:10.1371/journal.pone.0035518.g005
Figure 6. Dynamin 1 levels in the synaptosomal fraction of the
hippocampi of Btbd9 mutant mice. Image is a representative
Western blot analysis of dynamin in WT and Btbd9 mutant mice. Bar
graph is quantitative analysis of the Western blot, showing a significant
increase in dynamin 1 in the Btbd9 mutant mice. Bars represent means
6 SEM. * p=0.05.
doi:10.1371/journal.pone.0035518.g006
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proteins involved in synaptic plasticity will need to be conducted to
test these hypotheses.
In conclusion, the function of the BTBD9 protein is poorly
understood and no previous study has been designed to specifically
understand its normal function and potential role in the
pathophysiology of RLS. Here, we attempt to tackle this issue
by generating a line of Btbd9 mutant mice. Furthermore, using this
line of mutant mice, we have found that this protein regulates
hippocampal synaptic plasticity and fear memory. Further
research will need to be conducted to examine whether other
brain regions show similar abnormalities and the potential role of
BTBD9 in RLS.
Supporting Information
Figure S1 Location of the b-geo vector insertion site and
PCR map. (A) Schematic diagram of PCR reactions that were
used to narrow the b-geo vector insertion site to between 102,250
and 102,501. Reaction 1 produced PCR products at the
appropriate base pair (bp) length, whereas Reaction 2 failed to
produce reactions of the appropriate size, thereby narrowing the
location to between 102,000 to 102,501. This was further
confirmed by Reaction 3, which failed to produce reactions of
the appropriate size. This region was further broken down, with
Reactions 4 and 5. Reaction 4 produced PCR products at the
appropriate bp length, whereas Reaction 5 failed to produce
reactions of the appropriate size, thereby narrowing the location to
102,200 to 102,501. (B) Schematic diagram of PCR primer
locations used to genotype mice. A set of primers detects the wild-
type allele, and a different set of primers detects the mutant allele.
Base pair numbers are relative to the start of the sixth intron of the
Btbd9 gene. Thick line represents b-geo gene trap, and thin line
represents the sixth intron of the Btbd9 gene.
(TIF)
Figure S2 Response to electric shocks. (A) Btbd9 mutant
mice showed no difference in their threshold to electrical shock in
any of three measured behaviors – flinching, jumping, or
vocalization. (B) Btbd9 mutant mice showed no difference in
behavioral response on a rating scale of 1 to 5 to either of the
electric shocks during the training phase of the fear conditioning
experiment. (C) Btbd9 mutant mice showed no difference in
freezing behavior in the first 3 minutes of the cued fear
conditioning test. Bars represent means 6 SEM.
(TIF)
Figure S3 Western blot analyses of synaptic proteins
from hippocampal synaptosome fractions. Representative
Western blot images and quantitative analysis of SNAP-25 (A),
syntaxin (B), synaptotagmin (C), synaptophysin (D), and synapto-
brevin (E). Bars represent means 6 SEM.
(TIF)
Table S1 Primers located in the sixth intron of the
Btbd9 gene. Length is the number of nucleotides. Locations are
relative to the start of Intron 6 (intron between Exons 6 and 7).
(XLSX)
Table S2 Primers located in the b-geo gene trap vector.
Length is the number of nucleotides.
(XLSX)
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